130 related articles for article (PubMed ID: 2502794)
1. Activation in young rats induced by LY134046, an inhibitor of phenylethanolamine N-methyltransferase.
Mefford IN; Lawrenz AL; Hsiao JK; Crawley JN
Psychopharmacology (Berl); 1989; 98(2):240-4. PubMed ID: 2502794
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism.
Stolk JM; Vantini G; Perry BD; Guchhait RB; U'Prichard DC
J Pharmacol Exp Ther; 1984 Sep; 230(3):577-86. PubMed ID: 6147403
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of ethanol intoxication in rats by inhibitors of phenylethanolamine N-methyltransferase.
Mefford IN; Lister RG; Ota M; Linnoila M
Alcohol Clin Exp Res; 1990 Feb; 14(1):53-7. PubMed ID: 2178473
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of LY134046, an inhibitor of norepinephrine N-methyltransferase, in spontaneously hypertensive rats.
Hahn RA; Fuller RW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1983 Jul; 226(1):39-45. PubMed ID: 6864549
[No Abstract] [Full Text] [Related]
5. PNMT inhibition decreases exercise performance in the rat.
Trudeau F; Brisson GR; Péronnet F
Physiol Behav; 1992 Aug; 52(2):389-92. PubMed ID: 1523268
[TBL] [Abstract][Full Text] [Related]
6. The effects of two different inhibitors of PNMT and their interactions with ethanol.
Durcan MJ; Lister RG; Linnoila M
Neuroreport; 1992 Apr; 3(4):349-52. PubMed ID: 1515594
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of phenylethanolamine-N-methyltransferase: effects on brain catecholamine content and blood pressure in DOCA-salt hypertensive rats.
Liang NY; Chandra A; Tessel RE; Grunewald GL; Borchardt RT
Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):319-29. PubMed ID: 6515125
[TBL] [Abstract][Full Text] [Related]
8. Effects of catecholamine-depleting agents and receptor blockers on basal and angiotensin II- or norepinephrine-stimulated luteinizing hormone release in female rats.
Steele MK; Ganong WF
Endocrinology; 1986 Dec; 119(6):2728-36. PubMed ID: 3023020
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of the inhibitors of phenylethanolamine-N-methyltransferase, LY 78335 and LY 134046, and their interactions with ethanol.
Durcan MJ; Lister RG; Linnoila M
Psychopharmacology (Berl); 1990; 101(2):196-202. PubMed ID: 2349361
[TBL] [Abstract][Full Text] [Related]
10. Postnatal development of phenylethanolamine-N-methyltransferase activity of rat retina.
Cohen J
Neurosci Lett; 1987 Dec; 83(1-2):138-42. PubMed ID: 2894621
[TBL] [Abstract][Full Text] [Related]
11. Reduction of central epinephrine concentrations is consistent with the continued occurrence of ovulation in rats treated with an inhibitor (LY 134046) of phenylethanolamine N-methyltransferase.
Sheaves R; Laynes R; MacKinnon P
Neuroendocrinology; 1985 Nov; 41(5):432-6. PubMed ID: 3903538
[TBL] [Abstract][Full Text] [Related]
12. Acute cardiovascular effects of two central phenylethanolamine-N-methyl-transferase inhibitors in unanesthetized desoxycorticosterone-salt hypertensive rats.
Biollaz B; Biollaz J; Kohlman O; Bresnahan M; Gavras I; Gavras H
Eur J Pharmacol; 1984 Jul; 102(3-4):515-9. PubMed ID: 6489438
[TBL] [Abstract][Full Text] [Related]
13. Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor.
Pendleton RG; Kaiser C; Gessner G
J Pharmacol Exp Ther; 1976 Jun; 197(3):623-32. PubMed ID: 6786
[TBL] [Abstract][Full Text] [Related]
14. Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease.
Gearhart DA; Neafsey EJ; Collins MA
Neurochem Int; 2002 Jun; 40(7):611-20. PubMed ID: 11900856
[TBL] [Abstract][Full Text] [Related]
15. Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferase.
Fuller RW; Hemrick-Luecke S; Toomey RE; Horng JS; Ruffolo RR; Molloy BB
Biochem Pharmacol; 1981 Jun; 30(11):1345-52. PubMed ID: 6268095
[No Abstract] [Full Text] [Related]
16. Potentiation of L-DOPA induced motor activity by an inhibitor of phenylethanolamine-N-methyltransferase.
Katz RJ; Gelbart J; Carroll BJ
Prog Neuropsychopharmacol; 1980; 4(1):101-5. PubMed ID: 7190718
[No Abstract] [Full Text] [Related]
17. Soluble and particulate phenylethanolamine N-methyltransferase in hypothalamus of diabetic rats.
Chappell JE; Stewart JK
Am J Physiol; 1992 Aug; 263(2 Pt 1):E335-9. PubMed ID: 1514615
[TBL] [Abstract][Full Text] [Related]
18. Molecular recognition of sub-micromolar inhibitors by the epinephrine-synthesizing enzyme phenylethanolamine N-methyltransferase.
McMillan FM; Archbold J; McLeish MJ; Caine JM; Criscione KR; Grunewald GL; Martin JL
J Med Chem; 2004 Jan; 47(1):37-44. PubMed ID: 14695818
[TBL] [Abstract][Full Text] [Related]
19. Phenylethanolamine N-methyltransferase-immunoreactive terminals synapse on adrenal preganglionic neurons in the rat spinal cord.
Bernstein-Goral H; Bohn MC
Neuroscience; 1989; 32(2):521-37. PubMed ID: 2586760
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of 4-fluoro-8-substituted-2,3,4,5-tetrahydro-1H-2-benzazapines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
Grunewald GL; Caldwell TM; Li Q; Criscione KR
J Med Chem; 2001 Aug; 44(17):2849-56. PubMed ID: 11495596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
